2 recruiting, 1 completed, 1 terminated, 1 unknown. 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Recruiting 2, Completed 1, Terminated 1, Unknown 1, Withdrawn 1 |
Follow BK Virus Infection: new trials by email Literature Review of BK Virus Infection trials Research Report on BK Virus Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| R-MVST Cells for Treatment of Viral Infections in Children and Young Adults Rapidly generated virus specific T (R-MVST) cells - Epstein-Barr Virus, Cytomegalovirus Infections | Phase 1 | Recruiting | Monica Bhatia | 18 | 2025-04-20 | 2026-07-30 |
| Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients Virus-specific Cytotoxic T-lymphocytes - Adenovirus Infection, BK Virus Infection | Phase 1 | Terminated | M.D. Anderson Cancer Center | 12 | 2023-01-06 | 2026-08-11 |
| R-MVST Cells for Treatment of Viral Infections Rapidly generated virus specific T (R-MVST) cells - Epstein-Barr Virus Infections, Cytomegalovirus Infections | Phase 1 | Recruiting | Columbia University | 36 | 2022-05-03 | 2026-06-10 |
| BK With VST for Kidney Transplant Patients BK-specific T cells from Donor Lymphocytes - Kidney Transplant Infection, BK Virus Infection | Phase 1 | Completed | University of Wisconsin, Madison | 3 | 2021-12-16 | 2024-12-10 |
| Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient BD03 - Cytomegalovirus Infections, Preventation of Cytomegalovirus Reactivation | Phase 1 | Unknown | SL VAXiGEN | 18 | 2018-04-27 | 2018-07-03 |
| Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B) Viralym-B - BK Virus Infection | Phase 1 | Withdrawn | AlloVir | 2018-03-01 | 2018-04-09 |
Cytomegalovirus Infections (4) · Adenoviridae Infections (3) · Epstein-Barr Virus Infections (2) · Hematologic Neoplasms (1) · Immunologic Deficiency Syndromes (1) · Virus Diseases (1)
Infections (5) · DNA Virus Infections (4) · Herpesviridae Infections (4) · Virus Diseases (4) · Tumor Virus Infections (2) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Neoplasms (1) · Neoplasms by Site (1)
Cell Count (2)
AlloVir (1) · Columbia University (1) · M.D. Anderson Cancer Center (1) · Monica Bhatia (1) · SL VAXiGEN (1) · University of Wisconsin, Madison (1)
United States (5) · South Korea (1)
Bilal Omer, MD (1) · Jacques Galipeau, MD (1) · May Daher, MD (1) · Monica Bhatia, MD (1) · Pawel Muranski, MD (1) · Sandesh Parajuli, MD (1) · Swati Naik, MD (1)